Renal Cell Carcinoma and Proteomics | Zendy

Vanessa Sandim | Zendy; Denise de Abreu Pereira | Zendy; Antônio Augusto Ornellas | Zendy; Gilda Alves | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Renal Cell Carcinoma and Proteomics

Author(s) -

Vanessa Sandim,

Denise de Abreu Pereira,

Antônio Augusto Ornellas,

Gilda Alves

Publication year - 2010

Publication title -

urologia internationalis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.771

H-Index - 53

eISSN - 1423-0399

pISSN - 0042-1138

DOI - 10.1159/000296283

Subject(s) - renal cell carcinoma , medicine , proteomics , disease , oncology , bioinformatics , biology , biochemistry , gene

Renal cell carcinoma (RCC) represents 3% of adult malignancies. About 30% of RCC patients develop metastatic disease. So far, drugs cannot significantly increase the survival of these patients. We present a recent review of proteomics and RCC. Proteomic technologies have been used in the research to discover new markers of RCC that might increase survival. Furthermore, newly discovered markers cannot increase patient survival, rather their prognostic value supporting therapeutic decisions or new agents targeted at these new markers. More research is required to develop proteomic technologies and biomarkers for identification and validation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research